Expand CLNN Menu
CLNN MENU

CLNN Latest Press Releases

-- September 3, 2026 --

Clene to Present at Upcoming September Investor Conferences Globe Newswire 8:00 AM

-- August 19, 2026 --

Presenting on Emerging Growth Conference 95 Day 2 on August 20; Register to live stream Globe Newswire 7:00 AM

-- August 18, 2026 --

Presenting on Emerging Growth Conference 95 Day 1 on August 19; Register to live stream Globe Newswire 7:00 AM

-- August 17, 2026 --

Clene to Present at the Emerging Growth Conference Globe Newswire 8:30 AM

-- August 14, 2026 --

Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights Globe Newswire 8:30 AM

-- August 10, 2026 --

Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval Globe Newswire 8:00 AM

-- July 29, 2026 --

Clene to Present at The Canaccord 46th Annual Growth Conference Globe Newswire 8:30 AM

-- June 22, 2026 --

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis Globe Newswire 8:30 AM

-- May 14, 2026 --

Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights Globe Newswire 8:00 AM

-- May 6, 2026 --

Presenting on Emerging Growth Conference 92 Day 2 on May 7; Register to live stream Globe Newswire 7:00 AM

-- May 5, 2026 --

Clene Announces $7 Million Underwritten Offering of Common Stock Globe Newswire 8:45 AM
Clene to Present at Upcoming May Conferences Globe Newswire 8:00 AM
Presenting on Emerging Growth Conference 92 Day 1 on May 6; Register to live stream Globe Newswire 7:00 AM

-- May 4, 2026 --

After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes